MKI67 and neoplasm: HRs for disease recurrence according to prespecified baseline factors did not show any relevant heterogeneity in the effect of mitotane in specific subgroups stratified by patient age and sex, tumour size and stage, preoperative hormone secretion, hormone production, Ki67 index, Weiss score, and surgical approach (figure 3).